ALPINE IMMUNE SCIENCES, INC. Long-Term Debt, Maturity, Year Two
ALPINE IMMUNE SCIENCES, INC. had Long-Term Debt, Maturity, Year Two of $2.80 million as of 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2022-03-17
- 2021-12-31: Long-Term Debt, Maturity, Year Two $2.80M.
- 2021-09-30: Long-Term Debt, Maturity, Year Two $2.80M.
- 2021-06-30: Long-Term Debt, Maturity, Year Two $2.80M.
- 2021-03-31: Long-Term Debt, Maturity, Year Two $2.80M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2021-12-31 | $2.80M 10-K · filed 2022-03-17 |
| 2021-09-30 | $2.80M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.80M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $2.80M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $4.80M 10-K · filed 2021-03-18 |
| 2020-09-30 | $4.80M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.40M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $3.53M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.76M 10-K · filed 2020-03-30 |
| 2019-09-30 | $441.00K 10-Q · filed 2019-11-14 |
| 2018-12-31 | $2.00M 10-K · filed 2019-03-18 |